Investing in patient navigation and clinician incentives ensures colorectal cancer screening completion, improves early detection, reduces disparities, achieves cost savings, and advances population ...

(NewsNation) — More than 150,000 cases of colorectal cancer are estimated to have been diagnosed in the United States this year, but the overall rate of colon or rectal cancer diagnoses have dropped ...

Optimal stopping ages for colorectal cancer (CRC) screening depend on sex, comorbidity, and prior screening history, affecting cost-effectiveness and clinical outcomes. The MISCAN-Colon model ...

At-home collection, one-day fecal immunochemical test that meets American Cancer Society guidelines and HEDIS quality measures for lower gastrointestinal bleeding screening programs A number of ...

SAN DIEGO — In the ever-expanding options for colorectal cancer (CRC) screening, blood tests using precision medicine are becoming more advanced and convenient than ever; however, caveats abound, and ...

Colorectal Cancer Awareness Month is observed every year during March and aims to promote screening and early detection, raise awareness, and offer support to those battling the disease. Since March ...

Colorectal cancer stands as the third leading cause of cancer-related deaths in US men and the fourth leading cause in US women, according to the American Cancer Society. This year, over 150,000 ...

Even more colorectal cancer cases are being found in adults under 50, and a new collection of research suggests that a surge in screening may be tied to many of the more recent diagnoses – but not the ...

A groundbreaking blood test for colorectal cancer screening has received approval from the U.S. Food and Drug Administration (FDA), offering the potential to revolutionize early detection for one of ...

People invited to undergo FIT were more likely to participate in colorectal cancer screening compared with those invited to undergo colonoscopy. FIT was noninferior to colonoscopy for colorectal ...

Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...